MedTrace Logo

Immediate Effects of Kinesio Taping on Thoracic Outlet Syndrome

NCT07750184 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2026-08-10

No results posted yet for this study

Summary

The goal of this clinical trial is to evaluate the immediate effects of Kinesio Taping compared with sham taping in adults with Thoracic Outlet Syndrome (TOS). The study aims to determine whether a single application of Kinesio Taping provides greater improvements in symptom severity, grip strength, and hand dexterity than sham taping. The main questions it aims to answer are:

Does a single application of Kinesio Taping reduce symptom severity and improve tolerance to the Roos test compared with sham taping? Does a single application of Kinesio Taping improve grip strength and hand dexterity compared with sham taping? Researchers will compare participants receiving Kinesio Taping with those receiving sham taping to determine whether the observed effects are attributable to the therapeutic application of Kinesio Taping rather than nonspecific or placebo effects.

Participants will:

* undergo baseline assessments of symptom severity during the Roos test, Roos test completion time, grip strength, and hand dexterity;
* be randomly assigned to receive either Kinesio Taping or sham taping;
* undergo immediate post-intervention assessments using the same outcome measures.

Conditions

  • Thoracic Outlet Syndrome

Interventions

DEVICE

Kinesio Taping

A single application of therapeutic Kinesio Taping will be performed according to a standardized protocol by an experienced physiotherapist.

OTHER

sham taping- not therapeutic

A single application of sham taping will be performed according to a standardized protocol by an experienced physiotherapist.

Sponsors & Collaborators

  • Hacettepe University

    lead OTHER

Principal Investigators

  • FERAY KARADEMİR, PhD · Cumhuriyet University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-09-01
Primary Completion
2026-10-31
Completion
2026-12-31

Countries

  • Turkey (Türkiye)

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07750184 on ClinicalTrials.gov